{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:32:57Z","timestamp":1793748777524,"version":"4.6.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1097\/md.0000000000001528","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T08:48:26Z","timestamp":1445676506000},"page":"e1528","source":"Crossref","is-referenced-by-count":73,"title":["Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa"],"prefix":"10.1097","volume":"94","author":[{"given":"Giuseppina","family":"Annicchiarico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Morgese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Lattarulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilina","family":"Tampoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Bonamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigia","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Lapadula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210309","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2133.2009.09306.x","article-title":"Quality of life in patients with epidermolysis bullosa.","volume":"161","author":"Tabolli","year":"2009","journal-title":"Br J Dermatol"},{"key":"R2-4-20210309","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2008.02.004","article-title":"The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB.","volume":"58","author":"Fine","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R3-4-20210309","first-page":"637","article-title":"Mutations in KRT5 and KRT14 cause epidermolysis bullosa simplex in 75 of the patients.","volume":"164","author":"Bolling","year":"2011","journal-title":"Br J Dermatol"},{"key":"R4-4-20210309","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1073\/pnas.91.9.3549","article-title":"Dominant dystrophic epidermolysis bullosa: identification of a Gly-Ser substitution in the triple-helical domain of type VII collagen.","volume":"91","author":"Christiano","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R5-4-20210309","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1365-2133.2009.09041.x","article-title":"The Birmingham Epidermolysis Bullosa Severity score: development and validation.","volume":"160","author":"Moss","year":"2009","journal-title":"Br J Dermatol"},{"key":"R6-4-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-1172-8-132","article-title":"Prevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epidermolysis bullosa.","volume":"8","author":"Tampoia","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"R7-4-20210309","first-page":"63","article-title":"Epidermolysis bullosa and the partnership with autoimmunity: what should we assimilate Immunol R","volume":"61","author":"Esposito","year":"2015","journal-title":"es"},{"key":"R8-4-20210309","doi-asserted-by":"crossref","first-page":"e104479","DOI":"10.1371\/journal.pone.0104479","article-title":"Persistent release of IL-1s from skin is associated with systemic cardio-vascular disease, emaciation and systemic amyloidosis: the potential of anti-IL-1 therapy for systemic inflammatory diseases.","volume":"9","author":"Yamanaka","year":"2014","journal-title":"PLoS One"},{"key":"R9-4-20210309","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1053\/j.gastro.2011.08.052","article-title":"Gastrointestinal amyloidosis secondary to inherited skin disorder.","volume":"142","author":"Chen","year":"2012","journal-title":"Gastroenterology"},{"key":"R10-4-20210309","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000018384","article-title":"Renal amyloidosis in recessive dystrophic epidermolysis bullosa.","volume":"200","author":"Kaneko","year":"2000","journal-title":"Dermatology"},{"key":"R11-4-20210309","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/jid.2013.31","article-title":"The pathogenetic role of IL-1beta in severe epidermolysis bullosa simplex.","volume":"133","author":"Wally","year":"2013","journal-title":"J Invest Dermatol"},{"key":"R12-4-20210309","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1346-8138.2005.tb00790.x","article-title":"Increased serum levels of interleukin-6, immunoglobulin and acute phase protein in patients with the severe clinical form of inherited epidermolysis bullosa.","volume":"32","author":"Kawakami","year":"2005","journal-title":"J Dermatol"},{"key":"R13-4-20210309","first-page":"182","article-title":"HLA typing in epidermolysis bullosa patients: relevancy to gluten sensitivity.","volume":"4","author":"Annicchiarico","year":"2013","journal-title":"J Genet Syndr Gene Ther"},{"key":"R14-4-20210309","first-page":"677","article-title":"The risk of cardiomyopathy in inherited epidermolysis bullosa.","volume":"159","author":"Fine","year":"2008","journal-title":"Br J Dermatol"},{"key":"R15-4-20210309","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0272-6386(04)00935-7","article-title":"Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry.","volume":"44","author":"Fine","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R16-4-20210309","first-page":"138","article-title":"Improvement of renal function in epidermolysis bullosa patients after gluten free diet: two cases.","volume":"6","author":"Annicchiarico","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R17-4-20210309","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2012.08.002","article-title":"Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction.","volume":"40","author":"Samavedam","year":"2013","journal-title":"J Autoimmun"},{"key":"R18-4-20210309","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1093\/hmg\/ddu102","article-title":"Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-beta signalling in modifying disease severity.","volume":"23","author":"Odorisio","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R19-4-20210309","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1038\/sj.jid.5700918","article-title":"Induction of inflammatory cytokines by a keratin mutation and their repression by a small molecule in a mouse model for EBS.","volume":"127","author":"Lu","year":"2007","journal-title":"J Invest Dermatol"},{"key":"R20-4-20210309","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00917477","article-title":"Patients with severe forms of inherited epidermolysis bullosa exhibit decreased lymphokine and monokine production.","volume":"10","author":"Chopra","year":"1990","journal-title":"J Clin Immunol"},{"key":"R21-4-20210309","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archderm.1992.01680120073006","article-title":"Peripheral blood mononuclear cell subsets in patients with severe inherited forms of epidermolysis bullosa.","volume":"128","author":"Chopra","year":"1992","journal-title":"Arch Dermatol"},{"key":"R22-4-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/scrt511","article-title":"Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa.","volume":"5","author":"Perdoni","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"R23-4-20210309","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.0906-6705.2005.00316.x","article-title":"Keratinocyte-specific modulation of type VII collagen gene expression by pro-inflammatory cytokines (tumor necrosis factor-alpha and interleukin-1beta).","volume":"14","author":"Takeda","year":"2005","journal-title":"Exp Dermatol"},{"key":"R24-4-20210309","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/MCB.24.8.3168-3179.2004","article-title":"Thyroid hormones and gamma interferon specifically increase K15 keratin gene transcription.","volume":"24","author":"Radoja","year":"2004","journal-title":"Mol Cell Biol"},{"key":"R25-4-20210309","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1196\/annals.1398.020","article-title":"Autoimmune diseases are connected with disturbances in cytokine synthesis, and therapy with IFN-gamma blockers is their main pathogenetic treatment.","volume":"1109","author":"Skurkovich","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R26-4-20210309","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2011-12-396101","article-title":"IL-5 promotes induction of antigen-specific CD4CD25 T regulatory cells that suppress autoimmunity.","volume":"119","author":"Tran","year":"2012","journal-title":"Blood"},{"key":"R27-4-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2014.08.008","article-title":"Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behcets disease.","volume":"14","author":"Cantarini","year":"2015","journal-title":"Autoimmun Rev"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:49:50Z","timestamp":1620946190000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201510030-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":27,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001528","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}